Previous 10 | Next 10 |
Best Penny Stocks To Buy Social sentiment has become a major factor in finding the best penny stocks to buy. In the past, whatever people on Reddit, Twitter, Facebook, or even Discord were saying was taken with a grain of salt. Who pays attention to retail traders, right? The rise of ...
Amarin Corporation plc (AMRN) Q2 2022 Results Conference Call August 03, 2022 08:00 AM ET Company Participants Lisa DeFrancesco - SVP, IR and Corporate Affairs Karim Mikhail - President and CEO Dr. Steve Ketchum - President, R&D and Chief Scientific Officer ...
Best Penny Stocks To Buy Social sentiment has become a major factor in finding the best penny stocks to buy. In the past, whatever people on Reddit, Twitter, Facebook, or even Discord were saying was taken with a grain of salt. Who pays attention to retail traders, right? The rise of ...
Amarin press release ( NASDAQ: AMRN ): Q2 Non-GAAP EPS of -$0.09 misses by $0.03 . Revenue of $94.4M (-38.9% Y/Y) beats by $6.19M . This decrease was driven by a decline in volume and net selling price due to the impact of an increase in generic competition in ...
Company Received Final Positive Reimbursement Decision for VAZKEPA ® by UK’s NICE in England & Wales Market Access Negotiations and Launch Preparations for VAZKEPA Underway Across Multiple European Markets Initiated Comprehensive Cost Reduction Plan i...
Amarin ( NASDAQ: AMRN ) is scheduled to announce Q2 earnings results on Wednesday, August 3rd, before market open. The consensus EPS Estimate is -$0.06 and the consensus Revenue Estimate is $88.21M (-42.9% Y/Y). Over the last 2 years, AMRN has beaten EPS estimates ...
HLS Therapeutics ( OTCPK:HLTRF ) signed an agreement with Ontario, for listing and public reimbursement of heart drug Vascepa on the province's Public Prescription Drug Insurance Plan. Under the Product Listing Agreement (PLA), which was effective July 21, Vascep...
DUBLIN, Ireland and BRIDGEWATER, N.J., July 20, 2022 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with members of Amarin’s senior management team to discuss the Company’s second quarter 2022 financial results on W...
The Strategy performed in-line with its benchmark, as contributions in the consumer discretionary and energy sectors were offset by declines in industrials and financials. While current valuations are tilted toward a recession, trends in the labor market, energy commodities and corpor...
Shares of cardiovascular drug specialist Amarin (NASDAQ: AMRN) fell by another 9.2% through the first four days of trading this week, according to data provided by S&P Global Market Intelligence . As a result, the company's stock price has now dropped by a whopping 58% so fa...
News, Short Squeeze, Breakout and More Instantly...
Amarin Corporation plc Company Name:
AMRN Stock Symbol:
NASDAQ Market:
Amarin Corporation plc Website:
-- Portuguese Ministry of Health approves VAZKEPA® (icosapent ethyl) for national reimbursement to reduce the risk of cardiovascular (CV) events in patients with established cardiovascular disease (CVD) 1 -- -- Approval marks eighth national reimbursement of VAZKEPA®...
DUBLIN and BRIDGEWATER, N.J., July 17, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that it will host a conference call with Aaron Berg, President & CEO, and members of Amarin’s senior management team to discuss its second quarter 2024 results followed ...
-- VASCEPA Approved by the National Medical Products Administration (NMPA) To Reduce the Risk of Cardiovascular Events as an Adjunct to Statin Therapy in Adult Patients with Elevated Triglyceride (TG) Levels (≥150 mg/dL) and Other High-Risk Characteristics as Studied in REDUCE-IT -- ...